Learn about our research into whether prednisolone is beneficial, in terms of safety and effectiveness, in patients with early diffuse cutaneous scleroderma.
Learn about our research investigating whether the immune suppressant drug mycophenolate mofetil (MMF) can help to treat a subgroup of people with scleroderma.
Learn about our research into the possibility of combining clinical test results and blood sample analysis to identify patients who really need treatment.
Learn about our research into the development of a new app to help diagnose, assess, monitor and heal finger ulcers in patients with systemic sclerosis.
Calcinosis can sometimes occur in systemic sclerosis. Learn more about our research into developing a treatment for calcinosis that can be applied to the skin.
Learn about our research at University College London which investigates mycophenolate in limited cutaneous systemic sclerosis as part of an external pilot.
Learn about our research into methods of assessing the cause of shoulder pain, in order to find the best treatment based on individual characteristics.
Learn about our research into the cells and processes involved in frozen shoulder treatment, which aims to understand why it develops and how it gets better.
Read more about the development of a digital self-management tool for people with Sjögren’s syndrome (DIGITS) (DIGITS)
Learn about our research into why tertiary lymphoid organs (TLOs) are present in immune cells of Sjögren’s syndrome, their development and impact of removal.
Learn about our research into why rituximab isn't effective for Sjögren’s syndrome by using biological samples collected from our TRACTISS clinical trial.
Learn about the grant SALivary electro-stimulation for the treatment of dry mouth in patients with Sjogren's syndrome: a multicentRe randomISEd sham-controlled double-blind study (SALRISE).
Read about investigating how male sex hormones can influence the risk of developing juvenile systemic lupus erythematosus around puberty
Learn more about evaluating the potential of belimumab to treat patients with lupus who do not respond to rituximab.
Learn more about our research into interferon alpha: its influences on how lupus progresses and whether it affects patients’ response to rituximab therapy.
Read more about our research project which is investigating genetic variations in childhood and adult onset lupus and the normal function of the C1QTNF4 gene.
Learn about our research in precision type I interferon biomarkers for the stratification of autoimmune diseases - lupus, psoriatic arthritis, dermatomyositis.
Learn about our research project which investigates the link between levels of inflammation, iron and healthy mitochondria with fatigue in people with lupus.
Learn about our Clinical Research Fellowship grant aiming to understand the role of TAM receptors in lupus nephritis, based at the University of Manchester.
Learn more about understanding why blood vessels in people with lupus and antiphospholipid syndrome are damaged
Learn more about our research at the University of Manchester, which aims to understand the role of TAM receptors in systemic lupus nephritis/erythematosis.
Learn about our research which aims to understand why some people with systemic sclerosis are unable to regulate immune cells responsible for inflammation.
Read more about using artificial intelligence to monitor the progression of scleroderma and psoriatic arthritis.